DR REDDY'S LABORATORIES (UK) LIMITED
- Country
- United Kingdom
- Reference
- GB-COH-01729064
Dr Reddy's Laboratories (UK) Limited supplies pharmaceuticals and medical equipment to public buyers in England, with 9 public contract awards to NHS England and other buyers in London and Yorkshire and the Humber. Its awards total approximately £252,061,205 and run from 2025 to 2026, with 2025 the busiest year at 6 awards. Every award in the record is with NHS England, which accounts for all 9 contracts, and the work is concentrated in pharmaceutical categories grouped under medical equipment, pharmaceuticals and personal care products. The largest awards are the NHS National Framework for Transition products (Axitinib and Eltrombopag), valued at £52,385,000 and awarded in July and September 2025, and the NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin, valued at £25,881,000 and awarded in November 2025 and January 2026. The most recent award is the NHS National Framework for Transition Products (Nintedanib and Dalbavancin), dated April 2026, with an amount of £14,758,000; these amounts are framework ceilings shared among all suppliers, not sums paid to this company.
Interested in tenders like the ones DR REDDY'S LABORATORIES (UK) LIMITED wins? Get the next public tenders published in the United Kingdom in the same sectors and from the same buyers, by email. Free, no card needed.
Activity of DR REDDY'S LABORATORIES (UK) LIMITED in public procurement
By sector (CPV)
| CPV code | Awards |
|---|---|
| Pharmaceutical products 33600000 | 9 |
Activity by year
Recent awards
Open in El Vínculo →- NHS National Framework for Transition Products (Nintedanib and Dalbavancin) 25 February 2026
- NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin 25 November 2025
- NHS National Framework for Transition products (Axitinib and Eltrombopag) £52,385,00016 July 2025
- NHS National Framework for Transition products (Nilotinib and Ticagrelor) 12 June 2025
- NHS National Framework for Transition products (Nilotinib and Ticagrelor) 12 June 2025
- NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
- NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
- NHS National Framework for Transition products (Axitinib and Eltrombopag) £52,385,000
- NHS National Framework for Transition products (Nilotinib and Ticagrelor)
Contracting authorities that award contracts to DR REDDY'S LABORATORIES (UK) LIMITED
By region
| Place of performance | Awards |
|---|---|
| West Yorkshire | 2 |
| Inner London — East | 1 |
By amount range
Keywords
How can I find out about tenders like the ones DR REDDY'S LABORATORIES (UK) LIMITED wins?
Create an account at el-vinculo.com and we give you a free month and set up your company's filters — contract type, CPV codes, value and territory — so you are the first to know when new tenders come out in the United Kingdom in the same CPV codes and from the same buyers. We email you as soon as one matching your profile is published, with the whole deadline ahead to prepare the bid.
Explore more tenders
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.